Elsevier

Advances in Immunology

Volume 51, 1992, Pages 323-382
Advances in Immunology

The Pathobiology of Bronchial Asthma

https://doi.org/10.1016/S0065-2776(08)60491-5Get rights and content

Publisher Summary

This chapter discusses the recent developments in research on the pathobiology of the disease. The focus is on the cellular mechanisms of the disease as indicated by current information on the pathologic changes in the asthmatic bronchial mucosa obtained in living patients via the fiberoptic bronchoscope. The mediator mechanisms are addressed with special consideration of the possible role of the sulfidopeptide leukotrienes, prostanoid metabolites, and platelet-activating factor. Bronchial asthma is not a homogeneous disease and there are well-defined subgroups of patients. Heterogeneity in asthmatic syndromes is addressed by a consideration of two well-defined clinical subgroups—namely, aspirin-induced asthma and corticosteroid-resistant bronchial asthma. Bronchial asthma is a disease that is characterized by a history of episodic wheezing, by physiologic evidence of reversible airflow obstruction, either spontaneously or following bronchodilator therapy, and by pathologic evidence of inflammatory changes in the bronchial mucosa. Subsequent histological studies of the airways and examination of bronchoalveolar lavage fluid of subjects with mild asthma have confirmed the presence of airway inflammation in life. There is epithelial edema and desquamation, subepithelial deposition of collagen and fibronectin, and an inflammatory cell infiltrate in the mucosa.

References (310)

  • W.V. Filley et al.

    Identification by immunofluorescence of eosinophil granule major basic protein in lung tissue of patients with bronchial asthma

    Lancet

    (1982)
  • H. Otsuka et al.

    Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients

    J. Allergy Clin. Immunol.

    (1986)
  • D. Metcalf et al.

    Biologic properties in vitro of a recombinant human granulocyte-macrophage colony-stimulating factor

    Blood

    (1986)
  • Y.-C. Yang et al.

    Human IL-3 (multi-CSF): Identification by expression cloning of a novel hematopoietic growth factor related to murine IL-3

    Cell (Cambridge, Mass.)

    (1986)
  • W.J. Metzger et al.

    Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation

    Chest

    (1986)
  • S. Rak et al.

    The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients

    J. Allergy Clin. Immunol.

    (1988)
  • L. Osborn et al.

    Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes.

    Cell (Cambridge, Mass.)

    (1989)
  • G.I. Johnston et al.

    Cloning of GMP-140, a granule membrane protein of platelets and endothelium: Sequence similarity to proteins involved in cell adhesion and inflammation.

    Cell (Cambridge, Mass.)

    (1989)
  • J.B. Lowe et al.

    ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA.

    Cell (Cambridge, Mass.)

    (1990)
  • M.J. Elices et al.

    VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

    Cell (Cambridge, Mass.)

    (1990)
  • M.S. Dunnill

    The pathology of asthma, with special reference to changes in the bronchial mucosa

    J. Clin. Pathol.

    (1960)
  • K.C. Flint et al.

    Mel. Bronchoalveolar mast cells in extrinsic asthma: A mechanism for the initiation of antigen specific bronchoconstriction

    Br. Med. J.

    (1985)
  • R. Beasley et al.

    Cellular events in the bronchi in mild asthma and after bronchial provocation

    Am. Rev. Respir. Dis.

    (1989)
  • R. Agius et al.

    Mast cell and histamine content of human bronchoalveolar lavage fluid

    Thorax

    (1985)
  • J.G. Kirby et al.

    Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects

    Am. Rev. Respir. Dis.

    (1987)
  • A.J. Wardlaw et al.

    Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity

    Am. Rev. Respir. Dis.

    (1988)
  • M. Tomioka et al.

    Mast cells in bronchoalveolar lumen of patients with bronchial asthma

    Am. Rev. Respir. Dis.

    (1984)
  • M.C. Liu et al.

    Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma

    Am. Rev. Respir. Dis.

    (1990)
  • T.B. Casale et al.

    Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperrespon-siveness

    J. Clin. Invest.

    (1987)
  • P.K. Jeffery et al.

    Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity

    Am. Rev. Respir. Dis.

    (1989)
  • J. Bousquet et al.

    Eosinophilic inflammation in asthma

    N. Engl. J. Med.

    (1990)
  • R. Djukanovic et al.

    Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry

    Am. Rev. Respir. Dis.

    (1990)
  • S. Lozewicz et al.

    Inflammatory cells in the airways in mild asthma

    Br. Med. J.

    (1988)
  • M. Azzawi et al.

    Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma

    Am. Rev. Respir. Dis.

    (1990)
  • L.A. Laitinen et al.

    Damage of the airway epithelium and bronchial reactivity in patients with asthma

    Am. Rev. Respir. Dis.

    (1985)
  • G.D. Leikauf et al.

    Bradykinin stimulates Cl secretion and prostaglandin E2 release by canine tracheal epithelium

    Am. J. Physiol.

    (1985)
  • M.C. Holroyde

    The influence of epithelium on the responsiveness of guinea-pig isolated trachea

    Br. J. Pharmacol.

    (1986)
  • N.A. Flavahan et al.

    Respiratory epithelium inhibits bronchial smooth muscle tone

    J. Appl. Physiol.

    (1985)
  • C. Murlas

    Effects of mucosal removal on guinea-pig airway smooth muscle responsiveness

    Clin. Sci.

    (1986)
  • L.B. Schwartz

    Preformed mediators of human mast cells and basophils.

  • M.K. Church

    Is inhibition of mast cell mediator release relevant to the clinical activity of anti-allergic drugs?

    Agents Actions

    (1986)
  • L.S. Clegg et al.

    Histamine secretion from human skin slices induced by anti-IgE and artificial secretagogues and the effects of sodium cromoglycate and salbutamol

    Clin. Allergy

    (1985)
  • N.A.M. Paterson et al.

    Release of chemical mediators from partially purified human lung mast cells

    J. Immunol.

    (1976)
  • D.W. MacGlashan et al.

    Generation of leukotrienes by purified human lung mast cells

    J. Clin. Invest.

    (1982)
  • K.C. Flint et al.

    McI. Human mast cells recovered by bronchoalveolar lavage: Their morphology, histamine release and the effects of sodium cromoglycate

    Clin. Sci.

    (1985)
  • C.K.W. Lai et al.

    The mast cell in asthma.

  • W.J. Metzger et al.

    Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response

    J. Allergy Clin. Immunol.

    (1986)
  • P.C. Atkins et al.

    Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans

    Ann. Intern. Med.

    (1977)
  • N.G. Belcher et al.

    A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma

    Am. Rev. Respir. Dis.

    (1988)
  • L. Nagy et al.

    Neutrophil chemotatic activity in antigen-induced late asthmatic reactions

    N. Engl. J. Med.

    (1982)

    • Cited by (0)

    View full text
    Copyright © 1992 Academic Press Inc. Published by Elsevier Inc. All rights reserved.